At Adhera, we pride ourselves on identifying new uses for existing drugs and drug candidates, lowering risk while saving millions of dollars and years in development.
We specialize in advancing drugs for large areas of unmet medical need, maximizing the gap between expense and market opportunity. Some may call it brilliant; we call it innovation reimagined.
With 2 Phase-2 drugs in accelerated pathways, 4 large addressable markets of unmet needs, Adhera seeks to outstand in the biomedical market.
Investor RelationsAt Adhera, we pride ourselves on identifying new uses for existing drugs and drug candidates, lowering risk while saving millions of dollars and years in development.
With 2 Phase-2 drugs in accelerated pathways, 4 large addressable markets of unmet needs, Adhera seeks to outstand in the biomedical market.
Learn moreWith 2 Phase-2 drugs in accelerated pathways, 4 large addressable markets of unmet needs, Adhera seeks to outstand in the biomedical market.
Learn more
